20th Anniversary of the WHO FCTC Tobacco Control Framework

Feb.26.2025
20th Anniversary of the WHO FCTC Tobacco Control Framework
WHO celebrates 20th anniversary of tobacco control convention, marking major milestone in global public health efforts.

On February 25th, the World Health Organization announced that the WHO Framework Convention on Tobacco Control (WHO FCTC) is celebrating its 20th anniversary this week.


The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, stated that...


Tobacco is a scourge on humanity, being a leading cause of preventable death and disease worldwide.


Since the implementation of the WHO Framework Convention on Tobacco Control and its accompanying MPOWER technical package, global tobacco use has decreased by one-third over the past twenty years. The WHO Framework Convention on Tobacco Control has strengthened global tobacco control measures and helped save millions of lives. The convention is a milestone in public health and international law. We continue to urge countries to further strengthen and implement their measures, as well as call on countries that have not yet ratified the WHO Framework Convention on Tobacco Control to do so.


Since it was implemented 20 years ago, up to 5.6 billion people are currently covered by at least one tobacco control policy compliant with the treaty, and research shows a decrease in global smoking rates.


According to the Convention, a total of 138 countries require large graphic health warnings to be printed on cigarette packaging, with several dozen countries implementing plain packaging regulations for cigarettes, which mandate standard shapes and appearances for cigarette packages without any branding, design, or logos. Both measures are powerful tools in reducing tobacco consumption and warning users about the dangers of smoking.


Currently, more than a quarter of the global population is now benefiting from smoke-free policies, which require smoking to be banned indoors and in workplaces, thus saving millions of lives and protecting them from the dangers of secondhand smoke. Over 66 countries have implemented policies banning tobacco advertising, promotion, and sponsorship. These policies include prohibiting tobacco advertising and sponsorship agreements in the media, making it crucial for more countries to also take similar actions.


The tobacco industry is aggressive, spending billions of dollars to promote its products and actively undermining tobacco control efforts, including the implementation of the World Health Organization Framework Convention on Tobacco Control. The Framework Convention on Tobacco Control has played an important role in establishing legal defenses against this situation.


Adriana Blanco Marquizo, head of the World Health Organization's Framework Convention on Tobacco Control Secretariat, stated that,


The tobacco industry is a deadly industry behind the proliferation of tobacco, and now it is trying to position itself as part of the solution, while actively undermining tobacco control efforts that could save millions of lives. The World Health Organization's Framework Convention on Tobacco Control provides a comprehensive set of measures for parties to protect the public from the harmful strategies of the tobacco industry, which aim to profit at the expense of people's lives and the health of the planet. We urge parties to remain vigilant against their predatory strategies.


Despite significant progress in tobacco control, there is still a long way to go. The tobacco industry still causes millions of deaths each year, placing a significant socioeconomic burden on populations. We call on countries to fully implement measures outlined in the World Health Organization Framework Convention on Tobacco Control, including raising tobacco taxes, implementing smoke-free laws, fully banning advertising and sponsorship, banning and regulating tobacco product ingredients, and taking action to address the challenges posed by emerging tobacco and nicotine products. Through these measures, we can save millions of lives globally. We urge countries to double their efforts to ensure tobacco control remains a priority in public health and development.


Smoking is a key risk factor for noncommunicable diseases (NCDs), leading to premature death and disability. Tobacco-related illnesses result in catastrophic medical expenses, particularly for the poor, pushing families into a cycle of poverty. Smokers are more likely to experience food insecurity compared to non-smokers, even in wealthier countries. Furthermore, tobacco farming occupies a significant amount of land that could otherwise support sustainable food production systems.


Tobacco production further depletes important resources such as land and water, preventing them from being used for sustainable food production. In addition, billions of discarded plastic cigarette butts pollute ecosystems every year, further harming the planet.


The tobacco industry continues to undermine public health efforts by marketing, lobbying against tobacco control policies, actively targeting young people, and positioning themselves as part of the solution to the problems they cause.


The chairperson of the Conference of the Parties of the World Health Organization's Framework Convention on Tobacco Control, Reina Roa, added that...


The World Health Organization's Framework Convention on Tobacco Control is one of the greatest achievements in public health history. Since its establishment, and as a chair of the Conference of the Parties, I have witnessed its impact. I have continually seen how this treaty provides countries with the necessary tools to protect their populations from the devastating epidemic of tobacco. We celebrate the progress, commitments, and lives saved over the past 20 years of the World Health Organization's Framework Convention on Tobacco Control. Happy anniversary to the WHO FCTC.


The World Health Organization's Framework Convention on Tobacco Control is the first public health treaty negotiated under the auspices of the WHO, with 183 parties covering 90% of the global population. The convention provides a legal framework and a comprehensive set of evidence-based tobacco control measures under international law. These measures have saved millions of lives, including placing large health warning labels on cigarette packaging, implementing smoke-free laws, and increasing taxes on tobacco products.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Complete abstinence is not always the goal of addiction treatment under a harm-reduction approach, Japanese psychiatrist Tomohiro Shirasaka told 2Firsts in Manila. In the interview, he discussed patients' quality of life, Japan's shift towards heated tobacco products, and the challenges of quitting smoking for people with mental illness. Drawing on addiction treatment work in the Philippines, he advocated support rather than punishment and questioned whether fear-based health warnings effectively address the reasons people continue smoking.
Nov.10
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China's vape-related exports rose 4.5% year over year to $2.86 billion in the third quarter of 2026, led by stronger shipments to the United Kingdom as exports to the United States declined. UK-bound shipments increased 21.6%, adding $81.9 million, while US exports fell 5.2%, or $53.6 million. Growth weakened through the quarter, with September exports down 6.3% globally and 37.8% to the US. Nicotine-containing vape products accounted for more than 82% of the quarterly net increase, while device exports were nearly flat. Nine-month exports totaled $7.82 billion, up 4.0%.
DATA
Oct.26